90 related articles for article (PubMed ID: 10072934)
1. Chimeric dopamine D2/angiotensin AT1 receptors: role of the length of third intracellular loop of D2 receptors in conferring specificity of receptor binding and G-protein coupling.
Chen H; Zhang YY; Han QD
Zhongguo Yao Li Xue Bao; 1997 May; 18(3):209-13. PubMed ID: 10072934
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a chimeric human dopamine D3/D2 receptor functionally coupled to adenylyl cyclase in Chinese hamster ovary cells.
Van Leeuwen DH; Eisenstein J; O'Malley K; MacKenzie RG
Mol Pharmacol; 1995 Aug; 48(2):344-51. PubMed ID: 7651368
[TBL] [Abstract][Full Text] [Related]
3. High affinity agonist binding to the dopamine D3 receptor: chimeric receptors delineate a role for intracellular domains.
Robinson SW; Jarvie KR; Caron MG
Mol Pharmacol; 1994 Aug; 46(2):352-6. PubMed ID: 7915820
[TBL] [Abstract][Full Text] [Related]
4. Expression and pharmacological characterization of the human D3 dopamine receptor.
Freedman SB; Patel S; Marwood R; Emms F; Seabrook GR; Knowles MR; McAllister G
J Pharmacol Exp Ther; 1994 Jan; 268(1):417-26. PubMed ID: 8301582
[TBL] [Abstract][Full Text] [Related]
5. The influence of G protein subtype on agonist action at D2 dopamine receptors.
Nickolls SA; Strange PG
Neuropharmacology; 2004 Nov; 47(6):860-72. PubMed ID: 15527820
[TBL] [Abstract][Full Text] [Related]
6. Constitutive coupling of a chimeric dopamine D2/alpha 1B receptor to the phospholipase C pathway: inverse agonism to silent antagonism by neuroleptic drugs.
Wurch T; Boutet-Robinet EA; Palmier C; Colpaert FC; Pauwels PJ
J Pharmacol Exp Ther; 2003 Jan; 304(1):380-90. PubMed ID: 12490615
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the mechanism of agonist and inverse agonist action at D2 dopamine receptors.
Roberts DJ; Lin H; Strange PG
Biochem Pharmacol; 2004 May; 67(9):1657-65. PubMed ID: 15081865
[TBL] [Abstract][Full Text] [Related]
8. Human dopamine D3 and D2L receptors couple to inward rectifier potassium channels in mammalian cell lines.
Kuzhikandathil EV; Yu W; Oxford GS
Mol Cell Neurosci; 1998 Dec; 12(6):390-402. PubMed ID: 9888991
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic activity determinations at the dopamine D2 guanine nucleotide-binding protein-coupled receptor: utilization of receptor state binding affinities.
Lahti RA; Figur LM; Piercey MF; Ruppel PL; Evans DL
Mol Pharmacol; 1992 Sep; 42(3):432-8. PubMed ID: 1357542
[TBL] [Abstract][Full Text] [Related]
10. G protein coupling and ligand selectivity of the D2L and D3 dopamine receptors.
Lane JR; Powney B; Wise A; Rees S; Milligan G
J Pharmacol Exp Ther; 2008 Apr; 325(1):319-30. PubMed ID: 18218829
[TBL] [Abstract][Full Text] [Related]
11. SH3 binding domains in the dopamine D4 receptor.
Oldenhof J; Vickery R; Anafi M; Oak J; Ray A; Schoots O; Pawson T; von Zastrow M; Van Tol HH
Biochemistry; 1998 Nov; 37(45):15726-36. PubMed ID: 9843378
[TBL] [Abstract][Full Text] [Related]
12. Structural determinants of agonist-induced signaling and regulation of the angiotensin AT1 receptor.
Hunyady L; Gáborik Z; Shah BH; Jagadeesh G; Clark AJ; Catt KJ
Mol Cell Endocrinol; 2004 Mar; 217(1-2):89-100. PubMed ID: 15134806
[TBL] [Abstract][Full Text] [Related]
13. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
Sóvágó J; Makkai B; Gulyás B; Hall H
Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196
[TBL] [Abstract][Full Text] [Related]
14. Differential coupling of rat D2 dopamine receptor isoforms expressed in Spodoptera frugiperda insect cells.
Boundy VA; Lu L; Molinoff PB
J Pharmacol Exp Ther; 1996 Feb; 276(2):784-94. PubMed ID: 8632351
[TBL] [Abstract][Full Text] [Related]
15. Evidence that antipsychotic drugs are inverse agonists at D2 dopamine receptors.
Hall DA; Strange PG
Br J Pharmacol; 1997 Jun; 121(4):731-6. PubMed ID: 9208141
[TBL] [Abstract][Full Text] [Related]
16. I. NGD 94-1: identification of a novel, high-affinity antagonist at the human dopamine D4 receptor.
Tallman JF; Primus RJ; Brodbeck R; Cornfield L; Meade R; Woodruff K; Ross P; Thurkauf A; Gallager DW
J Pharmacol Exp Ther; 1997 Aug; 282(2):1011-9. PubMed ID: 9262370
[TBL] [Abstract][Full Text] [Related]
17. Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist.
Heinrich JN; Brennan J; Lai MH; Sullivan K; Hornby G; Popiolek M; Jiang LX; Pausch MH; Stack G; Marquis KL; Andree TH
Eur J Pharmacol; 2006 Dec; 552(1-3):36-45. PubMed ID: 17056032
[TBL] [Abstract][Full Text] [Related]
18. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
Odagaki Y; Toyoshima R
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1304-12. PubMed ID: 16824659
[TBL] [Abstract][Full Text] [Related]
19. Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides.
Boundy VA; Luedtke RR; Artymyshyn RP; Filtz TM; Molinoff PB
Mol Pharmacol; 1993 May; 43(5):666-76. PubMed ID: 8502224
[TBL] [Abstract][Full Text] [Related]
20. [3H] A-369508 ([2-[4-(2-cyanophenyl)-1-piperazinyl]-N-(3-methylphenyl) acetamide): an agonist radioligand selective for the dopamine D4 receptor.
Moreland RB; Terranova MA; Chang R; Uchic ME; Matulenko MA; Surber BW; Stewart AO; Brioni JD
Eur J Pharmacol; 2004 Aug; 497(2):147-54. PubMed ID: 15306199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
